Bdenza 40MG

Bdenza 40mg Capsule is a medication used to treat prostate cancer. Here are some key points about the product:

Composition:

Bdenza 40mg Capsule contains Enzalutamide, a non-steroidal anti-androgen medication.

Indications:

Bdenza 40mg Capsule is indicated for the treatment of:

1. Metastatic castration-resistant prostate cancer (mCRPC)
2. Non-metastatic castration-resistant prostate cancer (nmCRPC)

Mechanism of Action:

Enzalutamide works by:

1. Blocking the activity of androgen receptors in the prostate gland
2. Reducing the levels of testosterone and dihydrotestosterone (DHT) in the body
3. Inhibiting the growth of cancer cells that are dependent on androgens

Dosage and Administration:

The recommended dosage of Bdenza 40mg Capsule is:

• 40mg taken orally once daily, with or without food
• Take at the same time each day

Side Effects:

Common side effects of Bdenza 40mg Capsule include:

1. Fatigue
2. Headache
3. Nausea
4. Vomiting
5. Diarrhea
6. Hot flashes
7. Increased risk of falls

Serious side effects can include:

1. seizures
2. Hypersensitivity reactions (e.g., anaphylaxis)
3. Cardiovascular events (e.g., heart attack, stroke)
4. Liver damage

Contraindications:

Bdenza 40mg Capsule is contraindicated in patients with:

1. Hypersensitivity to Enzalutamide
2. Pregnancy or breastfeeding
3. Severe liver disease or liver impairment

Precautions:

1. Patients with a history of seizures or epilepsy should be closely monitored while receiving Bdenza 40mg Capsule.
2. Patients with a history of cardiovascular disease or cardiovascular risk factors should be closely monitored while receiving Bdenza 40mg Capsule.
3. Patients with a history of liver disease or liver impairment should be closely monitored while receiving Bdenza 40mg Capsule.

Patient Counseling:

• Patients should be counseled on the importance of taking their medication as directed and not missing doses.
• Patients should be instructed to report any signs of fatigue, headache, or nausea.
• Patients should be advised to report any changes in their appetite or weight loss.

Storage and Handling:

• Store bottles at room temperature between 15°C and 30°C (59°F and 86°F).
• Do not expose to direct sunlight or moisture.
• Use within 24 hours of opening.

Please note that the dosage and administration information is based on the recommended dosage and may vary depending on individual patient needs and circumstances.